Introduction
Congenital heart disease (CHD) is a common birth defect, with an incidence of nearly 1% in newborns (Roger et al, 2011) . The spectrum of abnormalities observed in CHD includes defects in the morphogenesis of the aortic arch arteries (AAAs). Interruption of the aortic arch is one of the most severe of these defects and is lethal unless corrected by surgery (Moon, 2006 (Moon, , 2008 . AAAs are an asymmetrical vascular tree that routes oxygenated blood from the heart to the rest of the body. These blood vessels develop from three pairs of pharyngeal arch arteries (PAAs) -numbered 3, 4, and 6 -that are initially organized symmetrically around the midline . Both the formation of PAAs and their subsequent asymmetrical remodeling are necessary for proper AAA morphogenesis. In this respect, mouse models of CHD indicated that AAA defects in patients with DiGeorge syndrome were likely due to aberrant. PAA formation Papangeli and Scambler, 2013a) , while AAA defects in patients with Allagile syndrome were likely the result of defective PAA remodeling (High and Epstein, 2008) . Taken together, these studies indicated that AAA morphogenesis is regulated over multiple steps during embryo development. Therefore, understanding the genes and mechanisms that regulate distinct steps in AAA morphogenesis will provide important insights into the etiology of CHD.
abnormal left-right patterning, defective development of the definitive endoderm, cardiac outflow tract, and cardiac neural crest (Mittal et al., 2010 (Mittal et al., , 2013 Pulina et al., 2011 Pulina et al., , 2014 Villegas et al., 2013) . However, it remained unclear whether cardiac and vascular defects observed in global Fn1-null embryos resulted directly from the role of Fn1 in cardiovascular development or from the earlier role of Fn1 in embryonic morphogenesis.
Integrins are a major class of Fn1 receptors (Wickstrom et al., 2011; Yang et al., 1999) , and at least 10 distinct integrins are known to bind Fn1 (Wickstrom et al., 2011) . To understand the mechanisms of Fn1 signal transduction during embryogenesis, several laboratories generated global knockout mice by deleting Fn1 receptors singly or in combination. The phenotypes of integrin α5-null embryos closely resemble those of Fn1-null mutants, while knockouts of other Fn1 receptors (e.g. integrin heterodimers containing αv, α4, α8, or α9 chains) do not correspond with Fn1-null phenotypes (Huang et al., 2009; Wickstrom et al., 2011; Yang et al., 1999) . Furthermore, our recent studies indicated that embryonic abnormalities related to defects in the left-right asymmetry, the development of the neural crest, and cardiogenesis in global Fn1-null embryos closely resembled defects observed in integrin α5-nulls (Mittal et al., 2010 (Mittal et al., , 2013 Pulina et al., 2011 Pulina et al., , 2014 Villegas et al., 2013) . Significantly, embryos in which the Arg-Asp-Gly (RGD) integrin-binding site in Fn1 was ablated displayed similar phenotypes when compared with integrin α5-null mutants (Takahashi et al., 2007) . These in vivo data, along with extensive molecular, biochemical, and cellular studies over the past four decades, have established that integrin α5β1 binds Fn1 and is a major Fn1 signal transducer. However, both the nature of the pathways activated by Fn1-integrin α5β1 interactions in vivo and the role(s) of these pathways in cardiovascular morphogenesis are virtually unknown.
In our previous work, we discovered that the expression of Fn1 is dynamically regulated during embryogenesis, and that Fn1 mRNA and protein are distributed in non-uniform patterns within the developing mouse embryo (Mittal et al., 2010; Pulina et al., 2014; Villegas et al., 2013) . In particular, we noticed that at E9.5, Fn1 is highly enriched in the pharyngeal arches 3, 4, and 6 (Mittal et al., 2010) . Fn1 is essential for vertebrate development and highly evolutionarily conserved (Hynes, 2012; Hynes and Zhao, 2000; Whittaker and Hynes, 2002) . Fn1 signals to cells by binding cell-surface integrins and syndecans. Cell adhesion to Fn1 regulates numerous cell biological functions such as proliferation, survival, and migration (Hynes, 2002 (Hynes, , 2009 Schwartz, 2010; Schwartz and Assoian, 2001 ). In addition, Fn1 binds a number of growth factors, including VEGF, HGF, and many Fgfs (Giancotti and Tarone, 2003; Hynes, 2009; Martino and Hubbell, 2010; Miyamoto et al., 1996; Wijelath et al., 2002) . Many growth factors require integrin-mediated cell adhesion to Fn1 for signaling (Giancotti and Tarone, 2003; Miyamoto et al., 1996) . Taken together, these studies suggest that the enrichment of Fn1 in distinct embryonic regions may be important to modulate cellular responses to growth factors and to regulate specific morphogenetic processes.
To test this hypothesis, we ablated Fn1 in the pharyngeal region using the Isl1 Cre knock-in strain of mice. In this strain, the Cre enzyme mediates recombination in several pharyngeal tissues including the pharyngeal and splanchnic mesoderm, endoderm, surface ectoderm and specific subpopulations of the cardiac neural crest (Cai et al., 2003; Engleka et al., 2012; Park et al., 2006) . Our studies indicate that distinct, cell type-specific pharyngeal sources of Fn1 play a number of distinct, indispensible roles in cardiovascular development and the formation of the 4th pair of PAAs. Moreover, we found that the phenotypes of Fn1 flox/− ; Isl1 Cre and integrin α5 flox/− ; Isl1 Cre mutants are similar with each other, indicating that integrin α5β1 acts as a major Fn1 receptor in the pharyngeal tissues. We then employed a series of conditional mutagenesis experiments to identify pharyngeal cell types, in which integrin α5-dependent signals regulate the development of distinct cardiovascular features.
Materials and methods

Mouse strains and genotyping
Fn1 +/− mice, integrin α5 +/− mice and integrin α5 flox/flox mice were a gift from Dr. Richard Hynes (George et al., 1997; van der Flier et al., 2010; Yang et al., 1993) . Fn1 flox/flox mice were a gift from Dr. Reinhardt Fassler (Sakai et al., 2001 ). Isl1 Cre knock-in mice were a gift from Dr. Sylvia Evans (Cai et al., 2003) . Rosa mTmG mice, Gt (ROSA)26Sortm4(ACTBtdTomato,-EGFP) were purchased from Jackson labs (Muzumdar et al., 2007) . Fn1 +/− mice or integrin α5 +/− mice were crossed with Isl1 Cre knock-in mice to generate Fn1 +/− ; Isl1 Cre/+ or integrin α5 +/− ; Isl1 Cre/+ males, respectively. To obtain embryos, Fn1 flox/flox females were crossed with Fn1 +/− ; Isl1 Cre/+ males and integrin α5 flox/flox females were crossed with integrin α5 +/− ; Isl1 Cre/+ males. Adult mice and embryos were genotyped as described (Cai et al., 2003; George et al., 1997; Sakai et al., 2001; van der Flier et al., 2010) . All experimental procedures were approved by the Institutional Animal Care and Use Committee of Thomas Jefferson University and conducted in accordance with federal guidelines for humane care of animals.
In situ hybridization
We generated the Fn1 in situ hybridization (ISH) probe and performed whole mount ISH staining procedure, as described (Mittal et al., 2010) . For the ISH on tissue sections, Fn1 probe recognizing the first exon of the Fn1 gene was purchased from the Advanced Cell Diagnostics (cat # 316951, ACD, Hayward, CA, USA). Detection was done using RNAscope 2.0 FFPE Assay Brown kit according to the manufacture's protocol. After the signal was developed, sections were counterstained with Gill's hematoxylin.
Intracardiac injection of India Ink
Embryos were dissected at E10.5 and fixed with 4% paraformaldehyde at 4 °C overnight. Embryos were rinsed with PBS and India ink injections were performed as described .
Immunofluorescence staining and histology
Dissected embryos were fixed with 4% paraformaldehyde at 4 °C overnight, rinsed in phosphate buffered saline (PBS), and stored in PBS at 4 °C for no more than 2 weeks. For paraffin embedding, embryos were processed through a graded series of alcohol and xylenes. Hematoxylin and eosin staining as well as alcian blue and nuclear fast red staining were done according to standard protocols. Alternatively, embryos were dehydrated through graded methanol series and stored at − 20 °C. For frozen sections, embryos were incubated in 30% sucrose in PBS until they sunk and then in 50/50 mix of 30% sucrose and optimum cutting temperature (OCT) compound (Tissue-Tek) at 4 °C overnight. Embryos were embedded in a 50/50 mix of 30% sucrose and OCT and frozen using isopentane/dry ice bath. The following primary antibodies were used to stain frozen sections: anti-integrin α5 (1:200, BD, cat #553319), anti-VEGFR2 (1:200, R&D, cat#AF644), anti-Pecam1 (1:200, BD Pharmingen, cat# 553370), anti-PDGFRβ (1:100; R&D, cat#AF1042), anti-NG2 (1:100, Millipore, cat#05-710), anti-ERG (1:100, Abcam, cat#ab110639). The following antibodies were used for either frozen or paraffin sections: rabbit polyclonal against mouse Fn1 (1:500, a gift from Dr. Richard Hynes lab, MIT) (George et al., 1993) , anti-GFP (1:500, Aves labs, cat #GFP-1020). For staining, sections were incubated with blocking buffer consisting of 10% Donkey serum in PBST (0.05% Tween 20 in PBS) for 1 h at room temperature (rt) and then incubated with primary antibodies diluted in blocking buffer overnight at 4 °C. The following day, sections were washed and then incubated with secondary antibodies: antimouse, anti-goat, anti-chicken, or anti-rabbit conjugated to Alexa-488, Alexa-555, or Alexa 647 (1:300, Invitrogen), or FITC-conjugated anti-chicken IgY antibodies (Jackson Immunoresearch). Nuclei were either stained with DAPI (1:1000 dilution of 5 mg/ml stock solution in H 2 O, Sigma, cat #32670-5MG-F) or DRAQ5 (1:1000 dilution of the stock solution supplied by Cell Signaling Technology, catalog #4048,). To extinguish the native tdTomato and memGFP fluorescence in frozen sections from embryos carrying the ROSA mTmG allele(s), sections were dehydrated through graded series of methanol and cover-slipped using glycerol:methanol (50:50) prior to imaging. For paraffin sections, the native tdTomato and memGFP fluorescence was extinguished by boiling sections in 10 mM Citric acid, pH6, for 10 min prior to staining. Slides were then mounted using ProLong® Gold Antifade (Invitrogen). All fluorescence images were acquired using an Olympus FV500 confocal microscope. Bright field images were acquired using Zeiss Axio Observer inverted microscope and DFC420 digital color camera (Leica).
For whole-mount immunofluorescence, embryos were isolated at E10.5 and fixed in 4% paraformaldehyde at 4 °C overnight. After rinsing, embryos were permeabilized with blocking buffer containing PBS, 0.1% Trixon X-100 (PBS-Triton) and 10% donkey serum at 4 °C overnight. The next day, embryos were incubated with anti-Pecam1 antibody (1:200, BD Pharmingen, cat #550274) for 48 h at 4 °C. Embryos were then washed for 4 to 6 hours using PBS-Triton and then incubated with Alexa-conjugated secondary antibodies (1:300, Invitrogen). Embryos were then washed for 24 h at 4 °C and incubated with DRAQ5 (1:1000) for 48 h. All incubations were performed with gentle rocking. Prior to imaging, embryos were dehydrated using a graded series of methanol and cleared using BABB solution consisting of benzyl alcohol (Sigma B-1042): benzyl benzoate (Sigma B-6630) in a 1:2 ratio. Z-stacks were acquired using an Olympus FV500 confocal microscope and analyzed using Imaris software (Bitplane, USA).
BrdU labeling
BrdU (Fisher Scientific, cat # BP2508250) was dissolved in PBS at 5 mg/ml. Pregnant females were injected with this solution at the dose of 30 mg of BrdU per 1 kg of mouse body weight when embryos reached E10.5 and were sacrificed 30 min after injection. To detect BrdU, sections were boiled for 10 min in 10 mM Citric acid solution, pH 6.0, and then stained using rat monoclonal anti-BrdU antibody (1:100, Abcam, cat #ab6326).
Outflow track measurements
The lengths of the proximal and distal portions of the cardiac outflow tract (OFT) and the height of the left ventricle were measured using the ruler tool in the AxioVision Zeiss image acquisition software as shown in Fig. 10 . To account for slight differences in the size of the heart, the OFT measurements were normalized relative to the height of the left ventricle.
Quantitative RT-PCR
We isolated pharyngeal arches 3-6 from α5 flox/+ ; Isl1 Cre control and integrin α5 flox/− ; Isl1 Cre mutant embryos at E10.5. RNA isolation, RT-PCR, quantification and primers sequences were as reported in .
Statistical methods
All statistics were performed using Prism 6 version of Graph-pad software. Data were analyzed using either 2-tailed unpaired Student's t-test or 2-tailed Fisher exact test, as indicated in the text and figure legends.
Results
Expression of Fn1 in tissues derived from Isl + progenitors is required for cardiovascular morphogenesis
Our previous studies indicated that the expression of Fn1 mRNA was enriched in the pharyngeal region corresponding with pharyngeal arches 3, 4, and 6 at E9.5 (Mittal et al., 2010) . Since the sequence of Fn1 is highly conserved in all vertebrates and is required for cardiovascular morphogenesis, we hypothesized that both tissue-specific synthesis of Fn1 and signaling by Fn1 to specific tissues were important for embryonic and cardiovascular development.
To test our hypotheses, we conditionally ablated Fn1 expression using the Isl1 Cre knock-in strain. The expression of Cre in this strain mediates loxP-dependent recombination in tissues that closely match those expressing Fn1 (Fig. 1A-A′ , B-B′) and leads to specific ablation of Fn1 mRNA and protein in the pharyngeal region (Fig. 1B-E, 1B′ -E′). The remaining Fn1 protein, as will be discussed later, is synthesized by the neural crest (long arrows in Fig. 1B-E) and in neural crest-derived cells (an open arrowhead in Fig. 1E′ ). We found that conditional deletion of Fn1 in Fn1 flox/− ; Isl1 Cre mutants resulted in late embryonic/early neonatal lethality in the majority of the cases (Table 1 ) and displayed a variety of cardiovascular and glandular abnormalities ( Fig. 2 and Table 2 ). Gross dissection of E16.5 mutant and control embryos indicated that the majority of Fn1 flox/− ; Isl1 Cre mutants exhibited defects in the morphogenesis of the AAAs, which included the interrupted aortic arch type B (IAA-B) (compare Fig. 2A and F) , aberrant origin of the right subclavian artery resulting in retroesophageal right subclavian artery (RERSA) (compare Fig. 2B and G, dotted line underlines RERSA), and defects in the branching of the carotid arteries (compare Fig. 2C and H) , Table 2 .
In addition to vascular abnormalities, we also found membranous and muscular cardiac ventricular septal defects (VSD) in n = 6/11 mutants (compare Fig. 2D -E with Fig. 2I-J) .
The positions of the great vessels, relative to the left and right ventricles of the heart, were unaffected in the majority of Fn1 flox/− ; Isl1 Cre mutants, except in one instance of the double outlet right ventricle (DORV) and one instance of persistent truncus arteriosus (PTA; compare Fig. 2K and M). In addition, most of the mutants developed nodules of subaortic cartilage, n = 7/11 (compare Fig. 2K , K′ and 2N, N′), and displayed defects in thymus morphogenesis, n = 7/11 (compare Fig. 2L , L′, and 2O, P), Table 2 . Myocardial thickness and trabeculation were unaffected in the majority of Fn1 flox/− ; Isl1 Cre mutants, n = 10/11.
The presence of membranous VSD was previously associated with direct and indirect defects in neural crest development (Hutson and Kirby, 2007) . Intriguingly, recent studies using the Isl1 Cre knock-in mice showed that Cre recombinase in this strain is activated in some populations of the neural crest-derived cells (Engleka et al., 2012) . To test whether Isl1 was expressed in the descendants of neural crest cells invading the cardiac outflow tract (OFT), we performed lineage-tracing studies using TFAP2α IRESCre to label neural crestderived cells. Simultaneously, we co-labeled sections using the antibodies to Isl1. For these and all other experiments involving immunofluorescence, the native GFP and tdTomato fluorescence due to the expression of the ROSA mTmG reporter was extinguished, as described in Methods. These experiments showed that Isl1 is expressed in the neural crestderived cells entering the cardiac OFT at E9.5 (Fig. 3A , A′). The majority of the neural crest cells in pharyngeal arches 3 (Fig. 3B , B′) and 4 ( Fig. 3C , C′) were Isl1-negative. This was also the case at E10.5 ( Fig. 3E-E′) . To exclude the mesodermal origin of cells co-expressing TFAP2α and Isl1 in the OFT, we performed lineage tracing using the Mesp1 Cre strain ( Fig.  3D -D′). Mesp1 is a transcription factor expressed in the earliest known mesodermal progenitors, which give rise to anterior mesodermal derivatives including the myocardium and endocardium of the heart (Saga et al., 2000) . These fate-mapping experiments showed that Isl1 + ; GFP + double-positive cells in the OFT, as seen in Fig. 3A -A′, are indeed derived from the neural crest and not from the mesoderm (arrows in Fig. 3D , arrowheads in 3D′). Cells expressing Isl1 in E10.5 pharyngeal arches mainly compose the endoderm, surface ectoderm, arch core mesoderm and PAA endothelium .
Taken together, these studies suggest that the membranous VSD and the peri-aortic cartilage observed in Fn1 flox/− ; Isl1 Cre mutants are a direct consequence of Isl1 Cre -mediated ablation of Fn1 in neural crest-derived cells. Indeed, we found that the deletion of Fn1 in the neural crest using either the TFAP2α IRESCre knock-in strain or the P3Pro-Cre transgenic line, resulted in the membranous VSD (n = 11/32) and peri-aortic cartilage (n = 10/12) (Fig. 4) .
Neural crest-derived cells are also known to play a requisite role in thymus development, contributing to the thymic capsule and the pericytes of thymic blood vessels (Foster et al., 2008; Hutson and Kirby, 2007; Le Douarin and Jotereau, 1975) . Since Fn1 flox/− ; Isl1 Cre , Fn1 flox/− ; TFAP2α IRESCre and Fn1 flox/− ; P3Pro-Cre mutants develop thymus defects ( embryos isolated at E16.5 appeared to be similar to that of controls; although, we noticed a somewhat disorganized appearance of pericytes in n = 2/3 Fn1 flox/− ; Isl1 Cre mutants (compare Fig. 5B , B′ with 5D, D′, and 5C, C′ with 5E, E′). With the bulk of thymic tissue derived from the Isl1 + pharyngeal endoderm of the 3rd pouch (Fig. 5A , GFP + cells), our data suggest that thymic defects in Fn1 flox/− ; Isl1 Cre mutants are likely due to the direct role of Fn1 in the development of this endodermal tissue and indirect role in the development of neural crest-derived pericytes. Taken together, our data indicate that the expression of Fn1 in Isl1 + cells and their descendants is required for ventricular septation, thymus development, and AAA morphogenesis. These phenotypes fall within a spectrum of abnormalities found in DiGeorge patients (Moon, 2008) .
Mouse models of DiGeorge syndrome indicate that AAA defects in DiGeorge patients, including IAA-B and RERSA, result from abnormal formation of the 4th pharyngeal arch arteries (PAAs) (Liao et al., 2004; Merscher et al., 2001; Papangeli and Scambler, 2013a) . In order to test whether this was the case in our mutants, we isolated E10.5 embryos at the time when all three pairs of PAAs were well-formed in controls and assayed PAA formation either by performing India ink injections into the hearts or by whole mount immunofluorescence staining and imaging. These assays indicated that the left or the right 4th PAAs were not formed properly in n = 8/18 Fn1 flox/− ; Isl1 Cre mutants, Table 3 (compare Fig. 6A (Fig. 6I) , indicating that defective formation of the 4th PAA was not due to differences in endothelial cell proliferation. The frequency of the 4th arch PAA defects in Fn1 flox/− ; Isl1 Cre mutants (44%) at E10.5 corresponds with the frequency of RERSA and IAA-B observed at E16.5 in Fn1 flox/− ; Isl1 Cre embryos (42%, Table 2 ), indicating that AAA anomalies in these mutants arose from defective formation of the 4th pair of PAAs.
Isl1 protein and the Cre recombinase in the Isl1 Cre strain label the pharyngeal endoderm, surface ectoderm, arch core mesoderm and PAA endothelium (Fig. 3E , E′, F, F′; and Supplemental Fig. 1 ), but not neural crest-derived cells in the pharyngeal arches ( Fig. 3 and Sup. Fig. 1 ). Consistent with these observations, the deletion of Fn1 in the neural crest did not result in PAA formation defects ( Fig. 6J-O′) . In these experiments, we used TFAP2α IRESCre , in which Cre is active in both the neural crest and the pharyngeal surface ectoderm. Taken together, these experiments indicate that these latter two pharyngeal sources of Fn1 are not required for PAA formation.
Integrin α5 is a major Fn1 receptor in Isl1 + cells and their descendants
Isl1 + progenitors contribute to multiple tissues within pharyngeal arches. These tissues comprise the pharyngeal endoderm, mesoderm (including PAA endothelium), and surface ectoderm (compare GFP + patterns in Fig. 7A and B; See Sup. Fig. 1 for the full anteriorposterior view of coronal section through the pharyngeal arches). Fn1 protein expression is enriched at the tissue borders in the pharyngeal arches (Fig. 7C) . Intriguingly, Fn1 mRNA is particularly highly expressed in the endoderm of the 4th pharyngeal arch (double-headed arrow in Fig. 7D ). In order to understand the mechanisms by which pharyngeal Fn1 regulates cardiovascular development, we performed conditional mutagenesis to identify Fn1 receptors and to determine the cell types responding to Fn1 signals in the pharyngeal arches. We focused our attention on integrin α5β1 since we and others have shown that phenotypes of integrin α5-null mice closely resemble those of Fn1-null mutants (George et al., 1993 (George et al., , 1997 Goh et al., 1997; Mittal et al., 2010 Mittal et al., , 2013 Pulina et al., 2011 Pulina et al., , 2014 Takahashi et al., 2007; Yang et al., 1999; Yang et al., 1993) .
Immunofluorescence staining indicated that integrin α5 is expressed in all pharyngeal cell types ( Fig. 7E ) and is particularly enriched in the PAA endothelium (e.g. open arrowheads in Fig. 7E and F) . To determine whether integrin α5β1 regulated cardiovascular morphogenesis downstream of Fn1, we used the Isl1 Cre knock-in mice to ablate integrin α5. This strategy resulted in efficient downregulation of integrin α5 in the surface ectoderm, splanchnic and pharyngeal mesoderm, myocardium, and in the endoderm in integrin α5 flox/− ; Isl1 Cre mutants at E8.5 (compare Fig. 8A , A′ and B, B′). At E10.5, we observed downregulation of integrin α5 in the PAA endothelium, endoderm and surface ectoderm in the pharyngeal arches of integrin α5 flox/− ; Isl1 Cre mutants (Fig. 8C , D and C′, D′). Taken together, these studies indicate that the use of the Isl1 Cre knock-in mice resulted in the downregulation of integrin α5 in the expected cell types.
The deletion of integrin α5 in tissues derived from Isl1 + cells was embryonic lethal in the majority of the cases (Table 4) , and resulted in phenotypes that closely corresponded with those observed in Fn1 flox/− ; Isl1 Cre mutants (Fig. 9) , Table 5 Tables 2 and 5 . However, this difference in frequency did not reach statistical significance (p = 0.14, 2-tailed Fisher exact test). Membranous VSD (n = 7/14), peri-aortic cartilage (n = 3/12) and thymus defects (n = 10/15) were present in integrin α5 flox/− ; TFAP2α IRESCre mutants (Fig. 9M-R) . Peri-aortic cartilage results from the abnormal differentiation of neural crest cells (Gao et al., 2010) . Taken together, our data suggest that signaling mediated by Fn1-integrin α5β1 interactions in neural crest cells is important for ventricular septation and suppression of differentiation of neural crest cells into the cartilage.
Analogous to Fn1 flox/− ; Isl1 Cre mutants, we found that defective PAA formation at E10.5 was the basis for RERSA and IAA-B defects in integrin α5 flox/− ; Isl1 Cre mutants (Fig. 10A-H) , Table 6 . The left, right, or both PAAs were affected in individual integrin α5 flox/− ; Isl1 Cre embryos, Table 6 . This is similar to the PAA phenotypes observed with Fn1 flox/− ; Isl1 Cre mutants (Fig. 6A-H′) . The slight increase in the incidence of bilateral PAA defects in integrin α5 flox/− ; Isl1 Cre mutants relative to Fn1 flox/− ; Isl1 Cre mutants (Table 6) was not statistically significant (p = 0.32, 2-tailed Fisher exact test). As in Fn1 flox/− ; Isl1 Cre mutants, endothelial proliferation was not affected in integrin α5 flox/− ; Isl1 Cre embryos (Fig. 10I) . Finally, deletion of integrin α5 in the neural crest and surface ectoderm using the TFAP2α IRESCre knock-in strain did not result in PAA formation defects (Fig. 10J-K′) . This indicates that signaling by integrin α5 in these tissues is dispensable for PAA formation. Taken together, similarities in the phenotypes between integrin α5 flox/− ; Isl1 Cre and Fn1 flox/− ; Isl1 Cre mutants suggest that Fn1 regulates cardiac morphogenesis and PAA formation by signaling through integrin α5.
Integrin α5 does not regulate the expression of Tbx1
Cardiovascular phenotypes of Fn1 flox/− ; Isl1 Cre and integrin α5 flox/− ; Isl1 Cre mutants fall within the range of phenotypes observed in DiGeorge syndrome. Therefore, we investigated whether integrin α5 regulates the expression of the transcription factor Tbx1. The Tbx1 gene is often deleted or mutated in DiGeorge patients (Moon, 2006 (Moon, , 2008 . Heterozygous deletion of Tbx1 in mice gives rise to defects in the formation of the 4th pair of PAAs and in AAA morphogenesis (Liao et al., 2004; Merscher et al., 2001 ). However, Tbx1 expression was unaffected in n = 4/4 integrin α5 flox/− ; Isl1 Cre mutants, suggesting that Tbx1 expression is not regulated by integrin α5 signaling in tissues derived from Isl1-expressing cells (Fig. 10L) .
Fn1 and integrin α5 regulate OFT morphogenesis
Proper vascular development is dependent on hemodynamic forces, and hence on the development and function of the heart (Culver and Dickinson, 2010; Lucitti et al., 2007; Luo et al., 2001) . Therefore, we examined cardiac development in Fn1 flox/− ; Isl1 Cre and integrin α5 flox/− ; Isl1 Cre mutants. In our previous studies using global, Fn1-null and integrin α5-null embryos, we discovered that Fn1 and integrin α5 were required for the elongation of the cardiac OFT (Mittal et al., 2013) . Since the global ablation of Fn1 or integrin α5 led to multiple embryonic morphogenetic defects, it was not clear whether Fn1 and integrin α5 played direct roles in OFT development. The OFT is derived from Isl1 + second heart field cells (Cai et al., 2003) . To determine whether defects in PAA formation were correlated with abnormal cardiac morphogenesis, we examined OFT development in E10.5 Fn1 flox/− ; Isl1 Cre mutants with defective and normal PAAs. Our data indicate that, on average, the relative lengths of the proximal and distal portions of the OFT were shorter in Fn1 flox/− ; Isl1 Cre and integrin α5 flox/− ; Isl1 Cre mutants compared with controls (Fig. 11) . However, when mutants were examined individually, defective PAAs were present in mutants with normal OFTs and normal PAAs were present in mutants with defective OFT (Fig. 11G) . Statistical analysis showed that the presence of short OFT did not correlate with defective PAA formation in the mutants (p = 0.16, Fisher exact test). Since myocardial development was unaffected in 91% of our mutants, Tables 2 and 5, we conclude that the roles of Fn1 and integrin α5 in PAA development are independent from their roles in OFT morphogenesis.
Integrin α5 regulates PAA formation indirectly
In order to identify the cell type(s) in which signaling by integrin α5 regulates PAA formation, we performed a series of conditional mutagenesis studies to ablate integrin α5 in distinct pharyngeal cell types. Since the expression of integrin α5 was downregulated in the PAA endothelium of integrin α5 flox/− ; Isl1 Cre mutants (Fig. 8C,C′,D , D′), we tested whether the expression of integrin α5 in the pharyngeal arch endothelium was required for the formation of the 4 th PAA. For these experiments, we used the knock-in Mesp1 Cre strain to ablate integrin α5, since Mesp1 + progenitors give rise to the entire pharyngeal mesoderm including the PAA endothelium Papangeli and Scambler, 2013b) . Our published studies indicated that the expression of integrin α5 in Mesp1-derived mesoderm, including the PAA endothelium was not required for PAA formation . This concurred with the observation that the deletion of integrin α5 in the endothelium using the transgenic Tie2-Cre mice did not cause defects in PAA formation (van der Flier et al., 2010) . Taken together, these studies indicate that integrin α5 regulates PAA formation indirectly by signaling from within the cell type(s) other than endothelial cells or the mesoderm. The corollary of these studies is that signaling by Fn1 to the pharyngeal mesoderm and endothelium is not required for PAA formation. Thus, signaling by Fn1 and integrin α5 to other pharyngeal tissues regulates PAA formation indirectly.
We next ablated integrin α5 in the neural crest using the P3-ProCre strain, or simultaneously, in the neural crest and the surface ectoderm using the TFAP2α IRESCre strain. PAA formation was unaffected in these mutants ( Fig. 10 and data not shown). Taken together, these data indicate that integrin α5-dependent signaling in a tissue other than the mesoderm, neural crest, and surface ectoderm is important for PAA formation.
Even though, integrin α5 is uniformly expressed by the pharyngeal endoderm (Figs. 7E, inset and 8C, C′), the expression of Fn1 mRNA is enriched specifically in the endoderm of the 4th pharyngeal arch (Fig. 7D ). This expression pattern is consistent with our findings that formation of the 4th PAA is selectively affected in Fn1 flox/− ; Isl1 Cre and integrin α5 flox/− ; Isl1 Cre mutants, and suggests that integrin α5-dependent signaling by Fn1 to the endoderm of the 4th pharyngeal arch may be particularly important. Although the expression of integrin α5 is lower in the endoderm of the 4th arch compared with other pharyngeal arch cell types (Figs. 7E and 8C′) at E10.5, its levels may be sufficient for signaling, especially, given the presence of enriched levels of Fn1 mRNA synthesized by these cells (doubleheaded arrow in Fig. 7D ). Thus, we propose a model, wherein an (as yet unknown) integrin α5-dependent signal from the pharyngeal endoderm regulates PAA formation (Fig. 12) .
Conclusions
Fn1 is highly conserved in all vertebrates (Hynes, 2012; Hynes and Zhao, 2000; Whittaker et al., 2006) ; it is prominently expressed around embryonic blood vessels, and its vascular expression and alternative splicing are tightly regulated upon injury in adult, reviewed by (Astrof and Hynes, 2009 ). However, direct roles of Fn1 in the development of the heart and blood vessels were obscured by severe morphogenetic defects that occurred at earlier stages of embryogenesis in global, Fn1-null embryos (George et al., 1997; George et al., 1993; Pulina et al., 2014; Pulina et al., 2011) . Our data show that Fn1 regulates the development cardiac and vascular structures, and highlight an intriguing discovery that localized, cellspecific expression of the secreted ECM glycoprotein Fn1 is essential for embryogenesis and cardiovascular development. We found that Fn1 synthesized by Isl1-expressing cells and their descendants is required for the morphogenesis of the cardiac OFT, for the formation of the cardiac interventricular septum, thymus development, and formation of the 4th pair of PAAs. Integrin α5 flox/− ; Isl1 Cre mutants displayed similar defects as Fn1 flox/− ; Isl1 Cre embryos, suggesting that integrin α5 acts as a main Fn1 receptor in the pharyngeal region. Taken together, our experiments provide the first evidence for the direct involvement of Fn1 and integrin α5 in the regulation of cardiovascular morphogenesis.
Discussion
Pharyngeal arches are composed of cells derived from all three embryonic germ layers and consist of the endoderm, mesoderm, surface ectoderm, and neural crest-derived (Hutson and Kirby, 2007) . The PAA endothelium is derived from mesodermal progenitors that express the Mesp1 transcription factor early in gastrulation Papangeli and Scambler, 2013b) . While the mechanisms of PAA formation are not well understood, PAA development is known to rely on signaling interactions among all cell types that compose the pharyngeal arch (Astrof, 2013) . PAA formation can be regulated directly, by signaling within the mesoderm, and indirectly, by signaling from the pharyngeal epithelia, the endoderm, and the surface ectoderm. For example, PAA formation requires the surface ectoderm to express the Tbx1 and Gbx2 transcription factors and the Fgf8 growth factor (Calmont et al., 2009; Macatee et al., 2003) . In the mesoderm, PAA formation requires the expression of Tbx1, PlexinD1, as well as activation of Notch and retinoic acid pathways (Gitler et al., 2004; High et al., 2009; Li et al., 2012; Zhang et al., 2009; Zhang et al., 2006) . Taken together, these and other studies illustrate the complex intercellular signaling interactions that regulate PAA formation.
In Fn1 flox/− ; Isl1 Cre mutants, Fn1 is ablated in the pharyngeal embryonic tissues that include splanchnic and pharyngeal mesoderm, pharyngeal endoderm, surface ectoderm, and select populations of neural crest cells. Which of these source(s) of Fn1 is(are) required for cardiovascular development, and do different sources of Fn1 regulate distinct morphogenetic processes? To address these questions we performed conditional mutagenesis studies by ablating Fn1 expression in distinct cell types within the expression domain that encompasses Isl1 + cells and their descendants. These studies showed that Fn1 expression in neural crestderived cells, surface ectoderm and their derivatives are important for thymus development, for blocking the differentiation of cardiac neural crest cells into the cartilage, and for the development of the membranous ventricular septum but are not required for the formation of the 4th PAA. Conditional mutagenesis studies to ablate Fn1 in other pharyngeal tissues are currently ongoing.
Identification of cell type(s) that regulate cardiovascular morphogenesis in response to Fn1 is essential for uncovering the downstream pathways engaged by Fn1 in vivo. To accomplish this, we first asked whether the expression of integrin α5β1 in Isl1 + tissues and their descendants was necessary for cardiovascular development and compared the phenotypes of integrin α5 flox/− ; Isl1 Cre embryos with those of Fn1 flox/− ; Isl1 Cre mutants. We found that the phenotypes of integrin α5 flox/− ; Isl1 Cre embryos are indistinguishable from those of Fn1 flox/− ; Isl1 Cre mutants, suggesting that Fn1 expressed by the pharyngeal tissues regulates cardiovascular morphogenesis by signaling through integrin α5β1.
Global mutation in integrin α5 led to severe cardiovascular defects, however, whether integrin α5 played a direct role in cardiovascular development was difficult to discern due to the complicating morphogenetic defects in these embryos (Pulina et al., 2011 (Pulina et al., , 2014 Yang et al., 1993) . Conditional knockouts of integrin α5 in a number of different cell types, such as endothelial cells, using the Tie2-Cre transgenic line (van der Flier et al., 2010) , in lymphatic endothelial cells and mesodermal precursors of mural cells, using the PDGFRβ-Cre transgenic line (Turner et al., 2014) , in the pharyngeal mesoderm and endothelium, using the Mesp1 Cre knock-in strain and in smooth muscle cells, using the SM22α-Cre transgenic line (Turner et al., 2015) , showed that the expression of integrin α5 in these cell types did not affect blood vessel formation. This suggested that concomitant signaling by integrin α5 from multiple cell types may be important for cardiovascular development (van der Flier et al., 2010) and/or that cardiovascular defects in global integrin α5-null embryos arose as a consequence of other embryonic abnormalities in these mutants (Goh et al., 1997; Mittal et al., 2010 Mittal et al., , 2013 Pulina et al., 2011 Pulina et al., , 2014 Yang et al., 1993) . Consistent with these ideas, the ablation of integrin α5 in multiple cell types using the Isl1 Cre knock-in strain demonstrated that integrin α5 expression in multiple pharyngeal tissues plays requisite roles in the regulation of cardiovascular morphogenesis. Particularly interesting is the role of integrin α5 and Fn1 in the formation of the 4th PAA. While we do not yet understand the mechanisms, it is important to note that the roles of integrin α5 and Fn1 in cardiac development are separate from their functions in the formation of the 4th PAAs, since cardiac and PAA defects occurred independently of one another.
To determine the cell types, in which signaling by α5β1 regulates cardiovascular development, we performed conditional mutagenesis studies to ablate integrin α5 in distinct tissues within the Is1-expression domain and its derivatives. We found that the expression of α5β1 in the neural crest or in the Mesp1-derived mesoderm was required for the formation of the membranous ventricular septum. These studies suggested that the expression of integrin α5β1 in both the neural crest-derived cells and the mesoderm jointly regulates the development of the membranous ventricular septum. Interestingly, and consistent with the studies of (Haack and Hynes, 2001; Turlo et al., 2012) , our work indicates that neither Fn1 nor integrin α5 are required for the migration of NC-derived cells.
Mesp1-derived cells include splanchnic mesoderm and all of the known pharyngeal mesodermal cells and their derivatives, such as the OFT and PAA endothelial cells. Interestingly, the expression of integrin α5 in the Mesp1-derived mesoderm was not required for PAA formation. Similarly, concomitant ablation of integrin α5 in the neural crest-derived cells and the surface ectoderm did not affect the formation of the PAAs. These studies suggest the pharyngeal endoderm as an important integrin α5 expression domain regulating PAA formation.
Fn1 and integrin α5 are prominently expressed in the pharyngeal endoderm at E8.5 (Figs.  1B′, 7D , and 8A-A′). At the later embryonic stages, the expression of integrin α5 diminishes but is clearly detectable in the endoderm of the pharyngeal arches at E10.5 (Figs.  7E and 8C, C′) . Remarkably, the expression of Fn1 mRNA becomes highly enriched in the endoderm of the 4th PAAs at E10.5 (Fig. 7D) , potentially explaining why the development of the 4th PAAs is particularly defective in Fn1 flox/− ; Isl1 Cre and integrin α5 flox/− ; Isl1 Cre mutants. Taken together with our conditional mutagenesis studies, these data suggest that Fn1 synthesized by the endoderm mediates the formation of the 4 th PAAs indirectly by signaling to the endoderm of the 4th pharyngeal arch through integrin α5β1. This hypothesis needs to be carefully and directly evaluated in the future, since many factors such as potential differences in strains' genetic backgrounds (all of our mice are on a mixed 129-C57BL/6J background), differences in the efficiency and timing of the genetic deletion, as well as other factors may influence PAA formation in the mutants utilized in our work. As an alternative to our model, concomitant integrin α5-dependent signaling in multiple pharyngeal tissues may be required to mediate PAA formation.
How pharyngeal endoderm may regulate PAA development is currently unknown. However, it is well established that both vasculogenesis and angiogenesis can be regulated by signals extrinsic to endothelial cells (Adams and Alitalo, 2007; Bressan et al., 2009; Garriock et al., 2010; Meadows et al., 2012) . By circumventing early embryonic lethality, our conditional mutagenesis strategy will facilitate identification of cellular and molecular mechanisms by which Fn1 and integrin α5β1 regulate embryogenesis and cardiovascular development.
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